IonQ Faces Short Seller Allegations and Revenue Questions Amid Share Price Decline

IonQ faces allegations of misrepresentation of revenues and loss of major Pentagon funding from short seller Wolfpack Research. The company has publicly contested the claims and emphasized its disclosures, governance, and deal-making. The stock price has declined 29.7% over the past month and 13.8% over the past year. Investors may focus on how IonQ addresses these claims and what additional disclosures or corporate actions follow.